Drug Topics
NOVEMBER 21, 2024
Premenstrual Dysphoric Disorder is considered a psychiatric disorder and is associated with moderate to severe physical, affective, and behavioral symptoms.
STAT
NOVEMBER 21, 2024
LONDON — The stacks of brightly colored disposable e-cigarettes, touting flavors like cotton candy ice and greengrape melon and often looming over the not-dissimilar-looking candy displays, have become a commonplace sight in convenience stores in both the U.S. and the U.K. But here, they’re on their way out.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
NOVEMBER 21, 2024
Investigators evaluated the role that cannabis plays in pain management in different populations with rheumatic diseases.
STAT
NOVEMBER 21, 2024
A dozen experts on women’s health are demanding the Federation of State Medical Boards remove a new documentary about menopause from its continuing medical education program over concerns the movie makes misleading and inaccurate statements about menopausal therapies. The film, called “ The M Factor: Shredding the Silence on Menopause ,” was released several weeks ago and can be seen on the Public Broadcasting System.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
NOVEMBER 21, 2024
“[O]ur data do not support the hypothesis that early COVID resulted in more significant structural or electrical cardiac remodeling that would increase the likelihood of atrial fibrillation progression,” the authors said.
STAT
NOVEMBER 21, 2024
Novartis said Thursday it purchased gene therapy startup Kate Therapeutics for up to $1.1 billion in upfront payments and milestones. It’s a rare buyout for a field that has quieted over the last couple years, amid a wider biotech downturn and questions about both the effectiveness and profitability of these one-time treatments. With the deal, Novartis will acquire a pipeline of preclinical gene therapies for three different genetic neuromuscular diseases, along with the under
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
NOVEMBER 21, 2024
Twenty years ago, cystic fibrosis wasn’t a household term for me. Today, cystic fibrosis — a genetic disorder that causes a buildup of thick, sticky mucus that can damage organs, especially the lungs — has become a centerpiece of my family’s lives, sending me on an advocacy mission to improve diagnosis and care for all families, regardless of their racial or ethnic background.
PharmaVoice
NOVEMBER 21, 2024
A subcutaneous version of Merck’s Keytruda was as effective as the infused version in a late-stage study, but the company won’t be the first to market.
STAT
NOVEMBER 21, 2024
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. Biotech M&A has been disappointing. Perhaps the trend will improve before we reach the holidays, but I can only opine on what’s transpired, and honestly, that’s not much.
Pharmacy Times
NOVEMBER 21, 2024
In this episode of Public Health Matters, Christina Madison discusses pharmacist-physician collaborations with Amina Abubakar and Stephen Lewis.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
NOVEMBER 21, 2024
Good morning, I’m back! And I can barely believe all the news that happened while I was away. On vacation, my biggest concern was a broken milkshake machine at a highway McDonald’s. Why are they always broken?? (Addendum: Editors know things! Mine just sent me this story in the Verge about an update to the “right to repair” issues that have long plagued McDonald’s franchise owners and their machines.
Fierce Pharma
NOVEMBER 21, 2024
As he introduced Novartis’ meet-the-management event Thursday in London, CEO Vas Narasimhan hammered home Novartis’ status as a streamlined, “pure-play, innovative medicines” company and the succes | Novartis has adjusted its compound annual growth rate expectation from 5%-plus to 6%-plus through 2029. The Swiss company cited the momentum of its current growth drivers, which have paved the way for a strong sales performance this year.
STAT
NOVEMBER 21, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hullo! Today, some squiddy drug delivery, a leukemia deal between Kura Oncology and Kyowa Kiri, and a new GLP-1 startup from Versant Ventures.
pharmaphorum
NOVEMBER 21, 2024
Discover how Within3's community-driven platform helps businesses gather and utilise data effectively. Explore our solution spotlight for insights into their innovative approach.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Compounding Pharmacy of America
NOVEMBER 21, 2024
Recently, a compound known as EGCG has emerged as a leading weight loss supplement. This new supplement offers hope for many people struggling with myriad health issues, including obesity. However, weight loss isn’t the only benefit to this amazing supplement. The post Your Guide to EGCG (Epigallocatechin-3-gallate) appeared first on The Compounding Pharmacy of America.
Drug Topics
NOVEMBER 21, 2024
Researchers explored the benefits of tai chi and prevalence of liver disease in patients with osteoarthritis.
pharmaphorum
NOVEMBER 21, 2024
Novartis has raised its guidance for sales growth out to 2029 on the strength of its pipeline and the potential of late-stage R&D assets
Drug Topics
NOVEMBER 21, 2024
James Rider, PharmD, shared reflections on his experiences as a pharmacy manager at CVS.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmaceutical Technology
NOVEMBER 21, 2024
Kura has partnered Kyowa Kirin in a strategic global collaboration for developing and commercialising oral ziftomenib to treat AML
Drug Topics
NOVEMBER 21, 2024
The Mediterranean diet is largely considered one of the healthiest diets.
Fierce Healthcare
NOVEMBER 21, 2024
Legislation that gives a president wide-reaching power to financially harm any nonprofit an administration deems as terrorist supporting passed out of the House of Representatives Nov. 21. | H.R. 9495 passed in the House on Thursday. If signed into law, a president would be able to take a nonprofit's tax-exempt status away without due process, critics say.
pharmaphorum
NOVEMBER 21, 2024
Shares in genetic testing company 23andMe continue to slide after prominent investors announce plans to sell their stakes.
Pharmacy Times
NOVEMBER 21, 2024
The indication is for adults with previously treated unresectable or metastatic HER2+ (IHC+) biliary tract cancer (BTC) as detected by an FDA-approved test.
pharmaphorum
NOVEMBER 21, 2024
Eisai has launched its new therapy for biliary tract cancer (BTC) Tasfygo in Japan, the first world market for the FGFR-targeting drug.
Pharmacy Times
NOVEMBER 21, 2024
No acute serious bacterial infections were observed in a trial of patients with the debilitating immune disorder, a strong mark of safety and tolerability.
STAT
NOVEMBER 21, 2024
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Robert Califf: Clinical care should drive AI adoption It’s day two of the FDA’s advisory committee meeting on regulating generative artificial intelligence tools.
Pharmacy Times
NOVEMBER 21, 2024
The supplemental new drug application (sNDA) is based on results from a phase 3 trial that enrolled patients with metastatic hormone-sensitive prostate cancer (mHSPC).
Fierce Pharma
NOVEMBER 21, 2024
Few pharmaceutical products have taken the market by storm like Roche’s Vabysmo. | Interim results from a late-stage trial of Roche's Vabysmo on Asian patients with polypoidal choroidal vasculopathy suggest that the injected treatment is effective. After 16 weeks, patients showed vision improvement which was equivalent to reading roughly one and a half more lines on an eye chart.
Pharmacy Times
NOVEMBER 21, 2024
There were 2 main types of switches, including switching to rituximab subcutaneous and switching among different intravenous rituximab treatments.
Fierce Healthcare
NOVEMBER 21, 2024
Not-for-profit hospital and health systems are slowly recovering from their worst year financially in 2022. | If federal lawmakers don't act to extend the Acute Hospital Care at Home program, which expires at the end of this year, it could dampen not-for-profit hospitals' nascent financial recovery, according to a new report from Fitch Ratings.
Pharmacy Times
NOVEMBER 21, 2024
Through an assignment to create a TikTok infomercial, students master new concepts and have positive educational experiences via social media.
Fierce Pharma
NOVEMBER 21, 2024
Merck and Johnson & Johnson are cutting staffers in China as they face local headwinds | Merck and Johnson & Johnson are cutting staffers in China as they face local headwinds, according to reports. Australia’s CSL is winding down operations at a cell and gene therapy R&D site in California. Kyowa Kirin inked a commercialization and development deal with Kuro Oncology.
Pharmacy Times
NOVEMBER 21, 2024
ALE.P02 could provide further treatment options for advanced or metastatic anti–claudin-1+ squamous cancers.
Expert insights. Personalized for you.
184 
Let's personalize your content